We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Green Plains
GPRE
$1.19B
| $1.18M | 0.01% |
+115,639
| New | +$852K |
|
|
TVRD
952
Tvardi Therapeutics
TVRD
$23.5M
| $1.16M | 0.01% |
+1,890
| New | +$1.04M |
|
953
Ironwood Pharmaceuticals
IRWD
$611M
| $1.16M | 0.01% |
112,644
-55,652
| -33% | -$570K |
|
|
USCR
954
DELISTED
U S Concrete, Inc.
USCR
| $1.16M | 0.01% |
46,647
-15,299
| -25% | -$307K |
|
955
Vanda Pharmaceuticals
VNDA
$312M
| $1.15M | 0.01% |
100,793
-546,667
| -84% | -$6.19M |
|
956
Zillow
ZG
$7.02B
| $1.15M | 0.01% |
+20,038
| New | +$987K |
|
957
Ameren
AEE
$31.5B
| $1.15M | 0.01% |
+16,324
| New | +$1.18M |
|
|
BIG
958
DELISTED
Big Lots, Inc.
BIG
| $1.15M | 0.01% |
+27,317
| New | +$776K |
|
|
VTLE
959
DELISTED
Vital Energy
VTLE
| $1.14M | 0.01% |
+82,566
| New | +$1.29M |
|
|
VRTV
960
DELISTED
VERITIV CORPORATION
VRTV
| $1.14M | 0.01% |
67,237
-14,683
| -18% | -$173K |
|
|
SFT
961
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $1.13M | 0.01% |
+8,703
| New | +$921K |
|
962
AMC Global Media
AMCX
$430M
| $1.13M | 0.01% |
48,134
-39,021
| -45% | -$1.02M |
|
|
HR
963
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.12M | 0.01% |
+38,109
| New | +$1.14M |
|
964
Zumiez
ZUMZ
$320M
| $1.11M | 0.01% |
+40,498
| New | +$920K |
|
|
GMS
965
DELISTED
GMS Inc
GMS
| $1.1M | 0.01% |
+44,908
| New | +$856K |
|
|
SRDX
966
DELISTED
Surmodics
SRDX
| $1.1M | 0.01% |
25,558
-27,352
| -52% | -$1.04M |
|
967
NWPX Infrastructure Inc
NWPX
$1.25B
| $1.1M | 0.01% |
43,793
-40,113
| -48% | -$955K |
|
968
MPLX
MPLX
$59.5B
| $1.1M | 0.01% |
+63,518
| New | +$1.08M |
|
969
iQIYI
IQ
$1.18B
| $1.1M | 0.01% |
47,244
+43,277
| +1,091% | +$803K |
|
970
Sony
SONY
$123B
| $1.09M | 0.01% |
+79,140
| New | +$1.03M |
|
971
WSFS Financial
WSFS
$4.1B
| $1.09M | 0.01% |
+37,861
| New | +$1M |
|
972
Copa Holdings
CPA
$5.56B
| $1.08M | 0.01% |
+21,461
| New | +$990K |
|
973
Quanterix
QTRX
$173M
| $1.08M | 0.01% |
+39,391
| New | +$995K |
|
974
Petrobras
PBR
$121B
| $1.07M | 0.01% |
129,808
-2,447,748
| -95% | -$17.7M |
|
975
Invitation Homes
INVH
$17.7B
| $1.07M | 0.01% |
+38,959
| New | +$976K |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.